Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2025.11.048 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Sasha Beyer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address: sasha.beyer@osumc.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Radiotherapy, Image-Guided, Patient Positioning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Susan G Komen Breast Cancer Foundation.
Abstract (Originalsprache)
PURPOSE: The challenges of postoperative accelerated partial breast irradiation (APBI) include targeting inaccuracies and inability to measure tumor response. We hypothesized that the tumor could be targeted with preoperative APBI (pAPBI) using magnetic resonance imaging (MRI) in prone position with our established prone breast technique. This feasibility study aimed to assess the accuracy and tumor response of pAPBI using our MRI/computed tomography (CT)-guided prone technology. METHODS AND MATERIALS: This prospective study enrolled patients aged >50 years with clinical stage IA ER+ breast cancer intending lumpectomy. Axillary ultrasound and MRI confirmed clinically negative nodes. Planning CT, MRI, and pAPBI (3850 cGy in 10 fractions twice a day) used the same prone immobilization platform. Another MRI was obtained 4 weeks after APBI to quantitatively measure tumor response. Lumpectomy was performed 4 to 6 weeks after pAPBI. Simon's 2-stage design required assessment after accrual of the first 19 patients for feasibility. RESULTS: Nineteen patients with clinical stage IA ER+/PR+/HER2- breast cancer with median age of 65 years (range, 51-78 years) completed pAPBI followed by lumpectomy and endocrine therapy. Median follow-up was 73.8 months (IQR, 58.6-82.5 months). Median clinical tumor size was 0.9 cm (IQR, 0.8-1.6 cm). There was complete pathologic response in 10.5% (2) patients and another 36.8% (7) were downstaged after pAPBI. MRI-detected tumor response significantly correlated with tumor response on pathology (P = .03). Cosmesis was rated as excellent/good in 89.5% (17) patients. Although 3 patients had macrometastases in nodes on final pathology despite a negative axillary ultrasound, local control was 95% and disease-free survival was 89.5% at a median follow-up of 73.8 months. CONCLUSIONS: Using the same prone platform, patients successfully underwent CT simulation, MRI acquisition, and pAPBI followed by lumpectomy. Nearly half of patients demonstrated tumor response to pAPBI on imaging and pathology. Further utilization of this technology can be highly applicable to the delivery of pAPBI, stereotactic body radiation therapy, or tumor bed boost radiation in the prone position.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address: sasha.beyer@osumc.edu.
- Department of Radiology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
- Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio.
- Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
- Department of Radiation Oncology, University of California Irvine Cancer Comprehensive Cancer Center, Orange, California.
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Förderung
- Susan G Komen Breast Cancer Foundation
Zitieren
APA
Beyer, S., Hawley, J., Gokun, Y., Yildiz, V. O., Wei, L., Jhawar, S., Crum, A., Healy, E., Stover, D., Carson, W., Farrar, W., Tozbikian, G., Poon, D., Bazan, J., Knopp, M., & White, J. (2025). Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.11.048
Vancouver
Beyer S, Hawley J, Gokun Y, Yildiz VO, Wei L, Jhawar S, et al. Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.11.048
BibTeX
@article{Beyer2025,
author = {Beyer, Sasha and Hawley, Jeffrey and Gokun, Yevgeniya and Yildiz, Vedat O and Wei, Lai and Jhawar, Sachin and Crum, Alexander and Healy, Erin and Stover, Dan and Carson, William and Farrar, William and Tozbikian, Gary and Poon, David and Bazan, Jose and Knopp, Michael and White, Julia},
title = {Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2025.11.048}
}
EUVIMED